IQVIA (IQV) News Today

IQVIA Holdings Inc. (IQV) shares are rising today as investors absorb a batch of stronger-than-expected earnings results, tighter guidance and multiple analyst upgrades that point to continued stabilization in biotech and pharma spending.

• Positive Sentiment: Medpace's 55% surge on a "shockingly strong" Q2 report lifted IQVIA alongside other contract research firms. Medpace Surges 55% On 'Shockingly Strong' Report; Pulling Iqvia Higher
• Positive Sentiment: UBS Group raised its target price on IQVIA from $185 to $225 and reiterated a "buy" rating, reflecting confidence in the company's growth trajectory. UBS Group Issues Positive Forecast for IQVIA (NYSE:IQV) Stock Price
• Positive Sentiment: Strong Q2 earnings across contract research firms signal that biotech and pharma R&D spending is stabilizing, boosting outlooks for IQVIA’s services. Contract Research Firms' Strong Earnings Signal Stabilizing Biotech, Pharma Spending
• Positive Sentiment: IQVIA tightened its full-year 2025 guidance ranges, a move that investors interpreted as management’s increased confidence in hitting its targets. Iqvia Shares Climb After Tightening of 2025 Guidance Ranges
• Positive Sentiment: IQVIA led S&P 500 gainers after reporting earnings that exceeded analyst expectations on both revenue and adjusted EPS. IQVIA Leads S&P 500 Gainers on Better-Than-Expected Earnings
• Positive Sentiment: IQVIA snapped a two-day losing streak as its quarterly results came in ahead of forecasts, lifting the stock off recent lows. IQVIA Holdings (IQV) Snaps 2-Day Losses on Higher-than-Expected Earnings
• Positive Sentiment: Evercore ISI boosted its target price for IQVIA, reflecting stronger demand trends in the company's core analytics business. Iqvia (IQV) Receives Target Price Boost from Evercore ISI | IQV Stock News
• Positive Sentiment: Truist Financial raised its price target on IQVIA from $209 to $235 and maintained a "buy" rating, implying a double-digit upside. IQVIA (NYSE:IQV) Price Target Raised to $235.00
• Positive Sentiment: William Blair reaffirmed its "outperform" rating on IQVIA, underscoring confidence in the company's long-term growth drivers. William Blair Reiterates Outperform Rating for IQVIA (NYSE:IQV)
• Positive Sentiment: IQVIA shares gapped up on its earnings beat, reflecting broad-based strength across all service lines. IQVIA (NYSE:IQV) Shares Gap Up on Earnings Beat
• Neutral Sentiment: An overview article explains the key drivers behind today’s IQVIA share move, including earnings, guidance and sector trends. Why IQVIA (IQV) Stock Is Trading Up Today
• Neutral Sentiment: A Benzinga roundup details the current consensus and mixed views among analysts covering IQVIA. Where IQVIA Hldgs Stands With Analysts
• Neutral Sentiment: Robert W. Baird bumped its target to $196 but kept a "neutral" rating, suggesting limited near-term upside. IQVIA (NYSE:IQV) Price Target Raised to $196.00 at Robert W. Baird
• Negative Sentiment: Barclays lifted its objective to $185 but maintained an "equal weight" stance, implying a downside risk of about 8% from current levels. Barclays Issues Positive Forecast for IQVIA (NYSE:IQV) Stock Price